Anbio Biotechnology (NNNN)
5.25
-0.35
(-6.25%)
USD |
NASDAQ |
Sep 18, 16:00
5.29
+0.04
(+0.76%)
After-Hours: 20:00
Anbio Biotechnology Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CureVac NV | -- |
| PAION AG | -- |
| Epigenomics AG | -2.521M |
| ACADIA Pharmaceuticals, Inc. | 3.815B |
| Alkermes Plc | 8.186B |
Enterprise Value Related Metrics
| Earnings Yield | 3.12% |
| Operating Earnings Yield | 2.81% |
| Normalized Earnings Yield | 3.173 |